Literature DB >> 8215446

Interaction of the amino-terminus of an influenza virus protein with mitochondria.

B M Woodfin1, A L Kazim.   

Abstract

Reye's Syndrome is characterized in part by liver mitochondrial damage. Previous studies in an animal model have demonstrated the presence of viral antigens in hepatocytes, but replication of the virus does not occur. Evidence is presented in this paper for the interaction of an influenza virus protein with mitochondria as a mechanism for mitochondrial damage in Reye's Syndrome. The amino-terminal 22 amino acids of the PB2 protein of influenza A interact with mitochondria alone (5 micrograms/mg mitochondrial protein) and, when conjugated to bovine serum albumin, mediate the binding of BSA to mitochondria (14 micrograms/mg mitochondrial protein).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8215446     DOI: 10.1006/abbi.1993.1533

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  4 in total

1.  The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon.

Authors:  Katy M Graef; Frank T Vreede; Yuk-Fai Lau; Amber W McCall; Simon M Carr; Kanta Subbarao; Ervin Fodor
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

Review 2.  Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine.

Authors:  Luis Martínez-Sobrido; Olve Peersen; Aitor Nogales
Journal:  Viruses       Date:  2018-10-15       Impact factor: 5.048

Review 3.  The influenza virus RNA polymerase as an innate immune agonist and antagonist.

Authors:  Elizaveta Elshina; Aartjan J W Te Velthuis
Journal:  Cell Mol Life Sci       Date:  2021-10-22       Impact factor: 9.261

4.  The PB2 Subunit of the Influenza A Virus RNA Polymerase Is Imported into the Mitochondrial Matrix.

Authors:  Joshua C D Long; Ervin Fodor
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.